Shipbroker BRS has questioned whether other VLCCs will be following an Okeanis Eco Tankers ship in cleaning up its tanks to carry refined oil. The Greek owner's 319,000-dwt VLCC Nissos Keros (built ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...

Even the CEOs of Big Pharmas have come under fire. Activist investor Starboard Value has made no secret of its criticism of Pfizer CEO Albert Bourla’s track record, while GSK CEO Emma Walmsley fought ...

The sarcopenia market size shall grow during the forecast period (2025–2034) due to the launch of upcoming therapies and the increasing cases ...

(Reuters) -Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can ...

View the latest Keros Therapeutics Inc. (KROS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Fintel reports that on June 10, 2025, B of A Securities downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from Buy to Neutral. Analyst Price Forecast Suggests 89.41% Upside As of ...

On Tuesday, BofA Securities adjusted its stance on Keros Therapeutics (NASDAQ: KROS), downgrading the stock from Buy to Neutral and reducing the price target from $32.00 to $18.00. The decision ...

Analyst cuts Keros rating to Neutral, citing limited near-term catalysts and cautious investor sentiment. $375M capital return announced, but unclear structure and delayed KER-065 updates weigh on ...